Asparaginase News and Research

RSS
Asparaginase is a drug which is given at the same time as chemotherapy drugs. It is an enzyme which deprives leukaemia cells of essential nutrients so that they die.
ERYTECH partners with Queen’s University to advance its product candidate for treating arginase-1 deficiency

ERYTECH partners with Queen’s University to advance its product candidate for treating arginase-1 deficiency

Enzyme identified in baker's yeast can efficiently annihilate leukemia cells

Enzyme identified in baker's yeast can efficiently annihilate leukemia cells

Study identifies risk factors for asparaginase-induced pancreatitis in ALL patients

Study identifies risk factors for asparaginase-induced pancreatitis in ALL patients

Novel biochemical method can extend lifetime of implantable medical devices

Novel biochemical method can extend lifetime of implantable medical devices

Pediatric chemotherapy regimen improves outcomes in young adults with ALL

Pediatric chemotherapy regimen improves outcomes in young adults with ALL

Intravenous PEG-asparaginase use recommended in paediatric ALL

Intravenous PEG-asparaginase use recommended in paediatric ALL

Jazz enrolls first patients in JZP-110 Phase 3 study for treatment of EDS in patients with narcolepsy or OSA

Jazz enrolls first patients in JZP-110 Phase 3 study for treatment of EDS in patients with narcolepsy or OSA

Researchers submit patent application for drug that could destroy acute lymphoblastic leukemia

Researchers submit patent application for drug that could destroy acute lymphoblastic leukemia

Jazz Pharmaceuticals to present defibrotide results for hepatic VOD at BMT Tandem meetings

Jazz Pharmaceuticals to present defibrotide results for hepatic VOD at BMT Tandem meetings

FDA approves intravenous administration of Erwinaze (asparaginase Erwinia chrysanthemi)

FDA approves intravenous administration of Erwinaze (asparaginase Erwinia chrysanthemi)

Comb-shaped polymers efficiently protect proteins in vivo

Comb-shaped polymers efficiently protect proteins in vivo

Jazz Pharmaceuticals offers $500 million aggregate principal amount of exchangeable senior notes

Jazz Pharmaceuticals offers $500 million aggregate principal amount of exchangeable senior notes

Sigma-Tau Rare Disease seeks EMA approval for use of Oncaspar for ALL treatment

Sigma-Tau Rare Disease seeks EMA approval for use of Oncaspar for ALL treatment

Jazz Pharmaceuticals' JZP-110 improves symptoms of EDS in adults with narcolepsy

Jazz Pharmaceuticals' JZP-110 improves symptoms of EDS in adults with narcolepsy

ERYTECH Pharma gets authorization to initiate Phase II study in pancreatic cancer

ERYTECH Pharma gets authorization to initiate Phase II study in pancreatic cancer

FDA grants orphan drug designation to ERYTECH’s lead product for AML treatment

FDA grants orphan drug designation to ERYTECH’s lead product for AML treatment

Jazz Pharmaceuticals' Versacloz now commercially available in the U.S. for schizophrenia

Jazz Pharmaceuticals' Versacloz now commercially available in the U.S. for schizophrenia

Scientists discover novel mechanism that influences GAS virulence at early steps of necrotizing fasciitis

Scientists discover novel mechanism that influences GAS virulence at early steps of necrotizing fasciitis

Research may lead to potential treatment for deadly bacterial infections

Research may lead to potential treatment for deadly bacterial infections

Research opens way to possible new treatments for bacterial infections

Research opens way to possible new treatments for bacterial infections